Clinical Trial Update: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/ml Polihexanide

View source ↗

Summary

A retrospective chart review of outcomes for patients with Acanthamoeba keratitis treated with 0.8 mg/mL polyhexanide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acanthamoeba Keratitis

Drugs mentioned

• Polihexanide (polyhexamethylene biguanide)

Snippet

Sponsor: SIFI SpA | Conditions: Acanthamoeba Keratitis | Status: COMPLETED